Role of DUOPA™ (carbidopa and levodopa Enteral Suspension) in Patients with Deep Brain Stimulation

被引:0
|
作者
Tauer, Aaron
Govindarajan, Raghav
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
57
引用
收藏
页码:S32 / S33
页数:2
相关论文
共 50 条
  • [1] Outpatient titration of carbidopa/levodopa enteral suspension (Duopa)
    Pahwa, Rajesh
    Lyons, Kelly E.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (05) : 459 - 465
  • [2] Duopa - A Carbidopa/Levodopa Enteral Suspension for Parkinson's Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2015, 57 (1474): : 112 - 112
  • [3] Carbidopa levodopa enteral suspension
    Seeberger, Lauren C.
    Hauser, Robert A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (18) : 2807 - 2817
  • [4] Pill burden reduction in patients with advanced Parkinson's disease: Comparative effectiveness of carbidopa/levodopa enteral suspension and Deep brain stimulation
    Soileau, M.
    Pagan, F.
    Fasano, A.
    Rodriguez-Cruz, R.
    Oh, M.
    Kandukuri, P.
    Jalundhwala, Y.
    Bao, Y.
    Kukreja, P.
    Siddiqui, M.
    MOVEMENT DISORDERS, 2020, 35 : S483 - S484
  • [5] Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Patients With Advanced Parkinson's Disease
    Soileau, M.
    Pagan, F.
    Fasano, A.
    Rodriguez, R.
    Gupta, N.
    Xi, A.
    Kambhampati, M.
    Murunga, A.
    Teigland, C.
    Kandukuri, P.
    Jalundhwala, Y.
    Ladhani, O.
    Siddiqui, M.
    MOVEMENT DISORDERS, 2021, 36 : S236 - S237
  • [6] Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson’s Disease
    Michael J. Soileau
    Fernando L. Pagan
    Alfonso Fasano
    Ramon Rodriguez-Cruz
    Connie H. Yan
    Niodita R. Gupta
    Christie L. Teigland
    Zulkarnain Pulungan
    Jill K. Schinkel
    Prasanna L. Kandukuri
    Omar A. Ladhani
    Mustafa S. Siddiqui
    Neurology and Therapy, 2023, 12 : 459 - 478
  • [7] Comparative Effectiveness of Carbidopa/Levodopa Enteral Suspension and Deep Brain Stimulation on Pill Burden Reduction in Medicare Fee-for-Service Patients with Advanced Parkinson's Disease
    Soileau, Michael J.
    Pagan, Fernando L.
    Fasano, Alfonso
    Rodriguez-Cruz, Ramon
    Yan, Connie H.
    Gupta, Niodita R.
    Teigland, Christie L.
    Pulungan, Zulkarnain
    Schinkel, Jill K.
    Kandukuri, Prasanna L.
    Ladhani, Omar A.
    Siddiqui, Mustafa S.
    NEUROLOGY AND THERAPY, 2023, 12 (02) : 459 - 478
  • [8] Quality of life in Deep Brain Stimulation and Duodenal Levodopa-Carbidopa Infusion patients
    Boonpang, Kamolwan
    Kaewwilai, Lalita
    Boonrod, Nonglak
    Devahastin, Ratanaruedee
    Jandeaw, Onnalin
    Jitkritsadakul, Onanong
    Jagota, Priya
    Bhidayasiri, Roongroj
    MOVEMENT DISORDERS, 2014, 29 : S16 - S17
  • [9] Efficacy of carbidopa/levodopa enteral suspension (CLES) in advanced Parkinson's disease patients previously treated with deep brain stimulation (DBS) - A subgroup analysis from PROviDE study
    Isaacson, S.
    Pahwa, R.
    Thakkar, S.
    Kandukuri, P.
    Jalundhwala, Y.
    Kukreja, P.
    Bao, Y.
    Gupta, N.
    Pan, I.
    Aldred, J.
    MOVEMENT DISORDERS, 2019, 34 : S48 - S49
  • [10] Levodopa/Carbidopa Enteral Suspension: A Review in Advanced Parkinson's Disease
    Hoy, Sheridan M.
    DRUGS, 2019, 79 (15) : 1709 - 1718